Track Categories
The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
This session at Stroke 2024 will delve into the forefront of stroke diagnosis and imaging technologies, including MRI, CT scans, DWI, and perfusion imaging. These advanced imaging modalities play a pivotal role in early stroke detection and accurate subtype classification, crucial for timely intervention and improved patient outcomes. Discussions will focus on novel biomarkers that enhance diagnostic precision, alongside imaging-guided treatment strategies that optimize therapeutic approaches. By integrating these technologies, clinicians can expedite the identification of ischemic and hemorrhagic strokes, facilitating prompt interventions such as thrombolysis and endovascular procedures. This session aims to showcase recent innovations in imaging technology and their impact on clinical decision-making, emphasizing the importance of early and accurate stroke diagnosis in reducing morbidity and mortality.
Addressing the global burden of stroke, this session will highlight innovative prevention strategies encompassing lifestyle modifications, pharmacological interventions, and emerging technologies such as wearable devices and telemedicine. Discussions will emphasize personalized prevention plans tailored to individual risk profiles, leveraging advancements in genetic screening and behavioral interventions to mitigate modifiable risk factors like hypertension, hyperlipidemia, and diabetes. Public health initiatives promoting population-based approaches to stroke prevention will also be explored, aiming to reduce incidence rates through community engagement and policy advocacy. By fostering collaboration between healthcare providers, researchers, and public health officials, this session seeks to advance comprehensive stroke prevention strategies that address both individual and societal health needs.
This session focuses on neuroprotective agents and interventions aimed at minimizing neuronal damage and enhancing brain recovery following stroke. Discussions will explore anti-inflammatory therapies, neurotrophic factors, and neurovascular protection mechanisms that hold promise in preserving neuronal integrity and improving long-term outcomes. Recent clinical trials evaluating the efficacy of neuroprotective strategies, including their potential for neurorecovery and functional restoration, will be highlighted. Emphasizing the role of precision medicine in tailoring treatments to individual patient needs, this session aims to advance the field by identifying novel therapeutic targets and optimizing their application in clinical practice. By addressing neuroprotection as a cornerstone of stroke management, this session aims to pave the way for innovative approaches that enhance patient recovery and quality of life.
This session will showcase recent advancements in ischemic stroke treatment, including thrombectomy procedures, neurovascular interventions, and neurorestorative therapies. Discussions will focus on breakthroughs in clot-busting drugs and endovascular techniques, highlighting their impact on improving recanalization rates and patient outcomes in acute stroke settings. The session will also address the integration of neurorehabilitation and neuroprotective strategies into acute care protocols, aiming to optimize functional recovery and minimize disability post-stroke. By exploring the latest evidence from clinical trials and real-world applications, this session aims to foster dialogue among clinicians, researchers, and industry leaders to accelerate the translation of emerging therapies into clinical practice. Ultimately, this session seeks to redefine standards of care in ischemic stroke management, offering new hope for patients and caregivers alike.
Focused on hemorrhagic stroke management, this session will explore advancements in neurosurgical techniques such as aneurysm clipping and coiling, alongside critical care interventions aimed at optimizing patient outcomes. Discussions will highlight minimally invasive procedures and personalized treatment algorithms that address the complexities of hemorrhagic stroke, including the role of care in stabilizing patients and preventing secondary brain injury. The session will also examine pharmacological innovations and rehabilitation strategies tailored to the unique needs of hemorrhagic stroke survivors, emphasizing multidisciplinary approaches to comprehensive stroke care. By bridging gaps in knowledge and practice, this session aims to empower healthcare professionals with the latest evidence and strategies for managing this challenging stroke subtype effectively.
This session will explore the pivotal role of neurorehabilitation in promoting functional recovery and improving quality of life for stroke survivors. Discussions will encompass evidence-based rehabilitation techniques, including robotic-assisted therapy, cognitive rehabilitation, and physical exercise programs tailored to individual patient needs. Emphasizing the principles of neuroplasticity and motor learning, the session will highlight innovative approaches that enhance brain reorganization and maximize recovery potential post-stroke. The integration of telemedicine and virtual rehabilitation platforms will also be discussed, addressing access barriers and expanding the reach of rehabilitation services to underserved populations. By advocating for early and intensive rehabilitation interventions, this session aims to optimize long-term outcomes and empower stroke survivors to regain independence and participation in daily activities.
This session will examine the application of precision medicine in stroke prevention, diagnosis, and treatment, leveraging genetic profiling, biomarkers, and personalized therapeutic strategies. Discussions will explore the role of pharmacogenomics in optimizing drug selection and dosing regimens, as well as the integration of big data analytics and machine learning algorithms in predicting stroke risk and treatment responses. The session will highlight innovative technologies such as digital health tools and bioinformatics platforms, which enable clinicians to deliver tailored care plans based on individual patient characteristics and genetic predispositions. By fostering interdisciplinary collaboration and technological innovation, this session aims to advance precision medicine as a cornerstone of stroke care, offering new avenues for improving patient outcomes and reducing healthcare disparities.
Addressing genetic factors influencing stroke susceptibility and prognosis, this session will explore recent advances in genomic research, genome-wide association studies (GWAS), and polygenic risk scores. Discussions will highlight the identification of stroke-related genes and their implications for personalized stroke prevention and treatment strategies. The session will also examine the role of genetic counseling in facilitating informed decision-making and family planning for individuals at risk of stroke. By elucidating the complex interplay between genetics, environment, and lifestyle factors, this session aims to pave the way for precision medicine approaches that optimize stroke care and enhance patient outcomes across diverse populations.
This session will explore the influence of lifestyle factors such as diet, physical activity, and environmental exposures on stroke incidence and risk reduction. Discussions will highlight the role of behavioral interventions in promoting healthy lifestyle choices and reducing modifiable risk factors like hypertension, obesity, and smoking. The session will also address population-based strategies and public health initiatives aimed at raising awareness and implementing policies that support stroke prevention through community engagement and health education. By advocating for comprehensive approaches to stroke risk management, including early detection and intervention, this session aims to empower individuals and communities to adopt healthier lifestyles and reduce the global burden of stroke.
This session will delve into the latest advancements in neurorehabilitation techniques aimed at optimizing functional recovery and enhancing quality of life for stroke survivors. Discussions will encompass robotic-assisted therapy, virtual reality, and task-specific training programs designed to promote neuroplasticity and motor learning. Emphasizing the importance of early and intensive rehabilitation, the session will highlight evidence-based approaches that address sensorimotor deficits, cognitive impairments, and psychosocial challenges post-stroke. The integration of telemedicine and remote monitoring platforms will also be explored, showcasing innovations that expand access to rehabilitation services and improve patient outcomes in diverse clinical settings. By fostering collaboration between researchers, clinicians, and technology developers, this session aims to advance the field of neurorehabilitation and drive improvements in stroke care delivery worldwide.
Focused on the unique challenges of pediatric stroke, this session will address epidemiology, etiologies, and management strategies tailored to children and adolescents. Discussions will highlight neonatal stroke, arterial ischemic stroke, and hemorrhagic stroke in younger populations, emphasizing the importance of early recognition and prompt intervention to optimize neurodevelopmental outcomes. The session will explore advancements in diagnostic imaging, neurocritical care, and rehabilitation therapies specifically designed for pediatric stroke patients, aiming to improve long-term functional outcomes and quality of life. By fostering collaboration among pediatricians, neurologists, and rehabilitation specialists, this session aims to advance clinical knowledge and enhance interdisciplinary care for pediatric stroke survivors worldwide.
This session will explore the concept of neuroplasticity and its implications for brain recovery and functional rehabilitation following stroke. Discussions will focus on adaptive neural circuits, motor learning, and cognitive rehabilitation strategies that promote brain reorganization and improve outcomes in stroke survivors. The session will highlight the role of intensive rehabilitation programs, environmental enrichment, and pharmacological interventions in enhancing neuroplasticity and facilitating neural repair post-stroke. By integrating research findings from neuroscience, rehabilitation medicine, and neurology, this session aims to elucidate mechanisms of neurorecovery and identify novel therapeutic targets for optimizing post-stroke rehabilitation. Ultimately, by advancing our understanding of neuroplasticity, this session seeks to drive innovations in stroke care and improve long-term functional outcomes for individuals affected by stroke.
This session will showcase the latest technological innovations in stroke rehabilitation, including robotic-assisted therapy, virtual reality, and wearable devices. Discussions will highlight the role of technology in enhancing motor learning, functional recovery, and patient engagement during rehabilitation sessions. The session will explore advancements in sensor technology, machine learning algorithms, and telemedicine platforms that facilitate remote monitoring and real-time feedback for stroke survivors. By integrating digital health solutions into clinical practice, this session aims to optimize rehabilitation outcomes expand access to care, and empower stroke survivors to regain independence and improve their quality of life. By fostering collaboration between engineers, clinicians, and rehabilitation specialists, this session aims to drive innovations in stroke rehabilitation and improve patient outcomes across diverse clinical settings.
This session will explore the role of telemedicine and remote monitoring in stroke care, highlighting advancements in telestroke networks, virtual consultations, and remote rehabilitation programs. Discussions will emphasize the benefits of telehealth in improving access to stroke specialists, facilitating timely interventions, and enhancing continuity of care for patients in underserved areas. The session will showcase telemedicine platforms that enable real-time clinical assessments, secure data transmission, and patient education for stroke survivors and their caregivers. By addressing challenges such as digital divide and healthcare disparities, this session aims to promote equitable access to stroke care and foster collaboration between healthcare providers, policymakers, and technology developers to advance telemedicine solutions in stroke management.
Focused on the intersection of stroke and cognitive health, this session will explore cognitive impairments such as aphasia , dysphagia , and executive dysfunction following stroke. Discussions will highlight neuropsychological assessments , cognitive rehabilitation , and supportive interventions aimed at optimizing cognitive function and quality of life for stroke survivors. The session will address long-term cognitive outcomes , predictors of cognitive decline , and integrated care models that promote brain health and functional independence post-stroke. By integrating insights from neurology , psychology , and rehabilitation sciences , this session aims to enhance clinical understanding of cognitive sequelae in stroke survivors and advance holistic approaches to stroke care that prioritize cognitive rehabilitation and support.
This session will examine the complex relationship between stroke and cardiovascular health, highlighting shared risk factors such as hypertension, atrial fibrillation, and diabetes mellitus. Discussions will emphasize integrated care models that address cardiovascular risk reduction, secondary stroke prevention, and multimodal therapies aimed at improving vascular health and outcomes for stroke survivors. The session will explore advancements in cardio-neurology, hypertension management, and antiplatelet therapies that optimize cardiovascular outcomes and reduce the risk of recurrent stroke. By fostering collaboration between cardiologists, neurologists, and primary care providers, this session aims to advance comprehensive care strategies that address the complex interplay between stroke and cardiovascular diseases, promoting vascular health and improving long-term outcomes for stroke survivors.
This session will explore the global epidemiology of stroke, highlighting regional variations, trends, and burden of the disease. Discussions will address health disparities, social determinants of health, and population-based interventions aimed at reducing stroke incidence and improving outcomes for affected individuals. The session will showcase stroke registries, surveillance systems, and public health policies that promote early detection, timely intervention, and community education on stroke prevention and management. By advocating for health equity and population health strategies, this session aims to empower policymakers, healthcare providers, and public health officials to implement effective interventions that address the global burden of stroke and reduce disparities in stroke care delivery.
This session will examine ethical dilemmas in stroke research, clinical practice, and healthcare delivery, addressing issues such as informed consent, equity in access, and patient autonomy. Discussions will explore ethical frameworks for clinical trials, genetic testing, and end-of-life care in stroke patients, emphasizing patient-centered ethics and healthcare justice in decision-making processes. The session will highlight ethical challenges in resource allocation, conflict of interest, and cultural competence in stroke care delivery, aiming to foster dialogue and consensus on ethical best practices among healthcare professionals and researchers. By promoting ethical literacy and guiding principles in stroke care, this session aims to uphold patient rights, integrity, and trust in clinical research and healthcare practice.
This session will focus on the unique challenges and considerations in geriatric stroke care, addressing epidemiology, clinical presentations, and management strategies tailored to older adults. Discussions will highlight the prevalence of stroke in aging populations, including vascular cognitive impairment, functional decline, and caregiver support. The session will explore multimodal approaches to stroke prevention, acute care, and rehabilitation, emphasizing comprehensive geriatric assessment and palliative care considerations in stroke management. By integrating insights from geriatrics, neurology, and rehabilitation medicine, this session aims to enhance clinical understanding and promote evidence-based care models that optimize outcomes and quality of life for elderly stroke survivors.
This session will explore the transformative role of artificial intelligence (AI) in stroke diagnosis, treatment planning, and patient management. Discussions will highlight advancements in AI-driven diagnostics, predictive modeling, and decision support systems that enhance clinical decision-making and personalized treatment in stroke care. The session will showcase machine learning algorithms, natural language processing, and image recognition technologies that enable automated interpretation of neuroimaging, genomic data, and electronic health records for stroke patients. By integrating AI-enabled tools into clinical practice, this session aims to improve diagnostic accuracy, workflow efficiency, and patient outcomes in stroke management, paving the way for precision medicine and data-driven healthcare innovations.
This session will explore the principles and practices of patient-centered care in stroke management, emphasizing patient preferences, shared decision-making, and quality of life outcomes. Discussions will highlight the importance of communication, empowerment, and care coordination in delivering personalized care plans that address the holistic needs of stroke survivors and their caregivers. The session will showcase patient-reported outcomes measures (PROMs), caregiver support programs, and community resources that promote patient engagement and long-term adherence to treatment regimens. By integrating patient-centered approaches into clinical practice, this session aims to improve patient satisfaction, health outcomes, and care delivery efficiency in stroke care settings, fostering a culture of empathy, respect, and collaboration among healthcare providers and patients.
This session will explore collaborative research initiatives and partnerships aimed at advancing stroke science, innovation, and translational research. Discussions will highlight multicenter trials, data sharing initiatives, and interdisciplinary collaborations that accelerate the translation of research findings into clinical practice. The session will showcase public-private partnerships, academic-industry collaborations, and global research networks that foster knowledge exchange and technology transfer in stroke research. By promoting team science and cross-sector collaboration, this session aims to address research gaps, scale innovation, and improve the reproducibility of findings in stroke research. Ultimately, by fostering a collaborative research ecosystem, this session seeks to accelerate the pace of discovery and innovation in stroke care, leading to improved patient outcomes and quality of life.
This session will examine clinical trials and translational research in stroke treatment and prevention, highlighting innovative therapies, trial design, and evidence-based practice. Discussions will explore phase I-IV trials, regulatory considerations, and patient recruitment strategies aimed at advancing therapeutic interventions and biomarker discovery in stroke care. The session will showcase bench-to-bedside approaches and proof-of-concept studies that bridge the gap between basic science discoveries and clinical applications in stroke medicine. By fostering dialogue among clinical investigators, research sponsors, and regulatory agencies, this session aims to promote rigorous research standards, ethical conduct, and data transparency in stroke clinical trials, ultimately translating scientific discoveries into tangible benefits for patients and caregivers.
This session will explore global perspectives on stroke care, policy, and healthcare delivery, highlighting international best practices, policy frameworks, and health system innovations that improve stroke outcomes and population health. Discussions will address healthcare disparities, access to care, and equitable distribution of stroke resources across different regions and socioeconomic contexts. The session will showcase country-specific initiatives, regional collaborations, and global health partnerships that promote stroke prevention, acute treatment, and rehabilitation services on a global scale. By advocating for policy change, advocacy efforts, and health diplomacy, this session aims to empower stakeholders, policymakers, and healthcare leaders to implement effective strategies that address the global burden of stroke and promote health equity for all populations.
This session will explore future directions in stroke research, innovation, and technology, highlighting emerging trends, challenges, and opportunities in the field. Discussions will focus on next-generation therapies, precision medicine, and digital health solutions that promise to transform stroke care delivery and patient outcomes in the coming years. The session will examine disruptive technologies, AI-driven diagnostics, and regenerative medicine approaches that hold potential for neuroprotection, neurorestoration, and functional recovery post-stroke. By fostering collaboration among researchers, clinicians, industry leaders, and policy makers, this session aims to shape the future of stroke research and innovation, driving advances that improve quality of life, reduce disability, and ultimately prevent strokes altogether.